HEPARIN - MECHANISM OF ACTION, PHARMACOKINETICS, DOSING CONSIDERATIONS, MONITORING, EFFICACY, AND SAFETY

被引：42

作者：

HIRSH, J

DALEN, JE

DEYKIN, D

POLLER, L

机构：

[1] UNIV ARIZONA, COLL MED, TUCSON, AZ 85721 USA

[2] VET ADM MED CTR JAMAICA PLAIN, BOSTON, MA 02130 USA

[3] WITHINGTON HOSP, NAT REFERENCE LAB ANTICOAGULANT REAGENT & CONTROL, MANCHESTER M20 8LR, LANCS, ENGLAND

来源：

CHEST | 1992年 / 102卷 / 04期

关键词：

D O I：

10.1378/chest.102.4.337S

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：S337 / S351

页数：15

共 225 条

[91]

HARENBERG J, 1990, SEMIN THROMB HEMOST, V16, P12

[92] HEPARIN FLUSHES AND THROMBOCYTOPENIA [J].

HEEGER, PS ;

BACKSTROM, JT .

ANNALS OF INTERNAL MEDICINE, 1986, 105 (01) :143-143

[93]

HEIT J, IN PRESS BLOOD

[94] LONG-TERM THERAPY WITH SUBCUTANEOUS HEPARIN DURING PREGNANCY [J].

HELLGREN, M ;

NYGARDS, EB .

GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1982, 13 (02) :76-89

[95]

HEMKER HC, 1987, 11TH C THROMB HAEM B, P17

[96]

HENNY CP, 1985, J LAB CLIN MED, V106, P187

[97] HEPARIN KINETICS IN VENOUS THROMBOSIS AND PULMONARY-EMBOLISM [J].

HIRSH, J ;

VANAKEN, WG ;

GALLUS, AS ;

DOLLERY, CT ;

CADE, JF ;

YUNG, WL .

CIRCULATION, 1976, 53 (04) :691-695

[98]

HIRSH J, 1992, BLOOD, V79, P1

[99]

HIRSH J, 1991, NEW ENGL J MED, V324, P1565

[100] TIME COURSES OF THE ANTITHROMBOTIC EFFECTS, BLEEDING ENHANCING EFFECTS AND INTERACTIONS WITH FACTORS-XA AND THROMBIN AFTER ADMINISTRATION OF LOW-MOLECULAR WEIGHT HEPARINOID ORG-10172 OR HEPARIN TO RATS [J].

HOBBELEN, PMJ ;

VOGEL, GMT ;

MEULEMAN, DG .

THROMBOSIS RESEARCH, 1987, 48 (05) :549-558

← 5 6 7 8 9 10 11 12 13 14 →